Share Price and Basic Stock Data
Last Updated: January 20, 2026, 11:27 pm
| PEG Ratio | 6.90 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Fundviser Capital (India) Ltd operates in the Finance & Investments sector, with a current market capitalization of ₹133 Cr. The company’s stock price stands at ₹225. The revenue trends have shown a significant fluctuation over the recent quarters. For instance, total sales recorded in March 2023 were ₹0.22 Cr, which rose to ₹0.97 Cr in March 2024, marking a notable increase. However, the revenues are still relatively low compared to industry standards, indicating a need for improved operational strategies. In the trailing twelve months (TTM), the reported revenue from operations was ₹2.30 Cr, reflecting a modest growth trajectory. The company’s quarterly sales peaked at ₹1.05 Cr in September 2025, suggesting potential for upward momentum. The operational performance, however, remains volatile, with some quarters reporting negative sales figures, which raises concerns about consistent revenue generation.
Profitability and Efficiency Metrics
Fundviser Capital’s profitability metrics present a mixed picture. The company’s operating profit margin (OPM) stood at 63.81%, which is considerably high compared to typical sector averages, indicating efficient cost management. Nevertheless, the net profit margin, which is reported at 8.00%, showcases the challenges in converting revenues to profit consistently. The return on equity (ROE) is low at 2.88%, reflecting limited returns for shareholders. The interest coverage ratio (ICR) of 24.75x indicates strong ability to meet interest obligations, showcasing financial health. However, the cash conversion cycle (CCC) stood at 79.06 days, which is relatively high, indicating potential inefficiencies in managing receivables and payables. Overall, while the company demonstrates strong operational efficiency, the profitability ratios signal areas requiring strategic improvement.
Balance Sheet Strength and Financial Ratios
Fundviser Capital’s balance sheet reflects a conservative approach towards debt management, with total borrowings reported at ₹3.80 Cr against total assets of ₹24.62 Cr as of September 2025. The debt-to-equity ratio stands at 0.35, indicating a low reliance on debt financing which is favorable for long-term sustainability. The company’s reserves have grown to ₹14.42 Cr, enhancing its financial cushion. The price-to-book value (P/BV) ratio is recorded at 3.58x, suggesting that the stock is trading at a premium relative to its book value, which could indicate market optimism. However, the return on capital employed (ROCE) at 3.76% remains below desirable levels, hinting at underutilization of capital. The current ratio of 1.33 suggests adequate liquidity to meet short-term obligations, reinforcing the balance sheet’s strength.
Shareholding Pattern and Investor Confidence
Investor confidence in Fundviser Capital is reflected in its shareholding pattern, where promoters hold 66.36% of the equity as of September 2025, indicating strong insider ownership and alignment with shareholder interests. However, the presence of domestic institutional investors (DIIs) is minimal at 0.42%, suggesting limited institutional interest. The public shareholding stands at 33.22%, which, while significant, indicates a potential lack of broader market confidence. The number of shareholders has shown a slight decline, from 4,010 in December 2022 to 3,736 in September 2025, which may raise concerns about retail investor sentiment. Overall, the concentrated promoter holding is a strength, but the low participation from DIIs and declining shareholder numbers may pose risks to market perception and liquidity.
Outlook, Risks, and Final Insight
Looking ahead, Fundviser Capital has the potential for growth, particularly if it can stabilize its revenue streams and improve profitability metrics. The high OPM suggests that operational efficiencies can be leveraged for better net profit outcomes. However, risks include the volatility in sales performance and the low ROE, which may deter potential investors. Additionally, reliance on a concentrated promoter base may limit the company’s appeal to a broader investor audience. If the company can enhance its operational strategies and attract institutional investment, it could strengthen its market position. Conversely, failure to address these challenges may lead to stagnation. The evolving market dynamics will require strategic agility to capitalize on emerging opportunities and mitigate inherent risks.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 11.7 Cr. | 40.0 | 58.0/36.4 | 46.9 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,220 Cr. | 280 | 482/275 | 14.3 | 111 | 0.36 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 30.9 Cr. | 0.44 | 1.34/0.38 | 4.28 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 4.48 Cr. | 9.06 | 11.6/8.25 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 19.8 Cr. | 38.6 | 69.9/38.5 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 7,216.31 Cr | 1,285.98 | 66.60 | 3,844.56 | 0.38% | 21.71% | 14.20% | 7.28 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.02 | 0.03 | -0.03 | 0.02 | 0.62 | 0.08 | 0.25 | 0.01 | 0.00 | 0.32 | 0.61 | 0.32 | 1.05 |
| Expenses | 0.05 | 0.06 | 0.07 | 0.06 | 0.05 | 0.07 | 0.20 | 0.04 | 0.09 | 0.70 | 0.77 | 0.64 | 0.38 |
| Operating Profit | -0.03 | -0.03 | -0.10 | -0.04 | 0.57 | 0.01 | 0.05 | -0.03 | -0.09 | -0.38 | -0.16 | -0.32 | 0.67 |
| OPM % | -150.00% | -100.00% | -200.00% | 91.94% | 12.50% | 20.00% | -300.00% | -118.75% | -26.23% | -100.00% | 63.81% | ||
| Other Income | 0.02 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 1.10 | 0.12 | 0.20 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Profit before tax | -0.01 | 0.12 | -0.10 | -0.04 | 0.57 | 0.01 | 0.05 | -0.03 | -0.08 | 0.72 | -0.04 | -0.13 | 0.64 |
| Tax % | 0.00% | 16.67% | -10.00% | -25.00% | 12.28% | 400.00% | 80.00% | -33.33% | -25.00% | 25.00% | -50.00% | 0.00% | 18.75% |
| Net Profit | -0.01 | 0.10 | -0.09 | -0.03 | 0.50 | -0.03 | 0.00 | -0.02 | -0.06 | 0.54 | -0.02 | -0.12 | 0.52 |
| EPS in Rs | -0.03 | 0.27 | -0.24 | -0.08 | 1.36 | -0.08 | 0.00 | -0.04 | -0.13 | 1.05 | -0.04 | -0.20 | 0.88 |
Last Updated: January 7, 2026, 8:33 am
Below is a detailed analysis of the quarterly data for Fundviser Capital (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1.05 Cr.. The value appears strong and on an upward trend. It has increased from 0.32 Cr. (Jun 2025) to 1.05 Cr., marking an increase of 0.73 Cr..
- For Expenses, as of Sep 2025, the value is 0.38 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.64 Cr. (Jun 2025) to 0.38 Cr., marking a decrease of 0.26 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.67 Cr.. The value appears strong and on an upward trend. It has increased from -0.32 Cr. (Jun 2025) to 0.67 Cr., marking an increase of 0.99 Cr..
- For OPM %, as of Sep 2025, the value is 63.81%. The value appears strong and on an upward trend. It has increased from -100.00% (Jun 2025) to 63.81%, marking an increase of 163.81%.
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.20 Cr. (Jun 2025) to 0.00 Cr., marking a decrease of 0.20 Cr..
- For Interest, as of Sep 2025, the value is 0.02 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Jun 2025) to 0.02 Cr., marking an increase of 0.02 Cr..
- For Depreciation, as of Sep 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.01 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.64 Cr.. The value appears strong and on an upward trend. It has increased from -0.13 Cr. (Jun 2025) to 0.64 Cr., marking an increase of 0.77 Cr..
- For Tax %, as of Sep 2025, the value is 18.75%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Jun 2025) to 18.75%, marking an increase of 18.75%.
- For Net Profit, as of Sep 2025, the value is 0.52 Cr.. The value appears strong and on an upward trend. It has increased from -0.12 Cr. (Jun 2025) to 0.52 Cr., marking an increase of 0.64 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.88. The value appears strong and on an upward trend. It has increased from -0.20 (Jun 2025) to 0.88, marking an increase of 1.08.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:43 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.21 | 3.61 | 0.00 | 0.00 | 0.34 | 0.25 | 0.28 | 0.24 | 0.15 | 0.22 | 0.97 | 2.17 | 2.30 |
| Expenses | 3.82 | 3.78 | 1.85 | 0.39 | 0.34 | 0.29 | 0.23 | 0.20 | 0.21 | 0.23 | 0.37 | 1.60 | 2.49 |
| Operating Profit | -0.61 | -0.17 | -1.85 | -0.39 | 0.00 | -0.04 | 0.05 | 0.04 | -0.06 | -0.01 | 0.60 | 0.57 | -0.19 |
| OPM % | -19.00% | -4.71% | 0.00% | -16.00% | 17.86% | 16.67% | -40.00% | -4.55% | 61.86% | 26.27% | -8.26% | ||
| Other Income | 0.17 | 0.23 | 3.27 | 0.49 | 0.00 | 0.13 | 0.01 | 0.60 | 0.05 | 0.00 | 0.00 | 0.00 | 1.42 |
| Interest | 0.02 | 0.03 | 0.00 | 0.06 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.02 |
| Depreciation | 0.30 | 0.68 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
| Profit before tax | -0.76 | -0.65 | 1.41 | 0.04 | -0.02 | 0.07 | 0.06 | 0.64 | -0.01 | -0.01 | 0.59 | 0.56 | 1.19 |
| Tax % | -5.26% | -24.62% | -8.51% | 25.00% | 50.00% | 0.00% | 66.67% | 17.19% | 200.00% | 0.00% | 25.42% | 23.21% | |
| Net Profit | -0.73 | -0.48 | 1.53 | 0.02 | -0.03 | 0.07 | 0.02 | 0.52 | -0.03 | -0.01 | 0.44 | 0.43 | 0.92 |
| EPS in Rs | -1.98 | -1.30 | 4.15 | 0.05 | -0.08 | 0.19 | 0.05 | 1.41 | -0.08 | -0.03 | 1.19 | 0.83 | 1.69 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 34.25% | 418.75% | -98.69% | -250.00% | 333.33% | -71.43% | 2500.00% | -105.77% | 66.67% | 4500.00% | -2.27% |
| Change in YoY Net Profit Growth (%) | 0.00% | 384.50% | -517.44% | -151.31% | 583.33% | -404.76% | 2571.43% | -2605.77% | 172.44% | 4433.33% | -4502.27% |
Fundviser Capital (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | 47% |
| 3 Years: | 135% |
| TTM: | 30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 85% |
| 3 Years: | 154% |
| TTM: | -24% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 100% |
| 3 Years: | 142% |
| 1 Year: | 49% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 3:30 pm
Balance Sheet
Last Updated: December 4, 2025, 2:54 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 4.47 | 5.15 | 5.92 |
| Reserves | 0.73 | 0.25 | 1.78 | 2.04 | 2.00 | 2.08 | 2.10 | 2.62 | 2.52 | 2.79 | 8.76 | 11.43 | 14.42 |
| Borrowings | 0.42 | 0.13 | 0.40 | 0.19 | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.80 |
| Other Liabilities | 0.55 | 0.20 | 0.14 | 0.05 | 0.06 | 0.03 | 0.20 | 0.13 | 0.02 | 0.06 | 0.09 | 0.23 | 0.48 |
| Total Liabilities | 5.39 | 4.27 | 6.01 | 5.97 | 6.11 | 5.80 | 5.99 | 6.44 | 6.23 | 6.54 | 13.32 | 16.81 | 24.62 |
| Fixed Assets | 2.22 | 1.54 | 0.09 | 0.08 | 0.08 | 1.17 | 1.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.19 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.03 | 0.02 | 0.52 | 0.69 | 0.65 | 0.17 | 0.17 | 0.17 | 3.09 | 3.20 | 2.61 | 11.53 | 12.92 |
| Other Assets | 3.14 | 2.71 | 5.40 | 5.20 | 5.38 | 4.46 | 4.53 | 6.27 | 3.14 | 3.34 | 10.71 | 5.23 | 11.51 |
| Total Assets | 5.39 | 4.27 | 6.01 | 5.97 | 6.11 | 5.80 | 5.99 | 6.44 | 6.23 | 6.54 | 13.32 | 16.81 | 24.62 |
Below is a detailed analysis of the balance sheet data for Fundviser Capital (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 5.92 Cr.. The value appears strong and on an upward trend. It has increased from 5.15 Cr. (Mar 2025) to 5.92 Cr., marking an increase of 0.77 Cr..
- For Reserves, as of Sep 2025, the value is 14.42 Cr.. The value appears strong and on an upward trend. It has increased from 11.43 Cr. (Mar 2025) to 14.42 Cr., marking an increase of 2.99 Cr..
- For Borrowings, as of Sep 2025, the value is 3.80 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2025) to 3.80 Cr., marking an increase of 3.80 Cr..
- For Other Liabilities, as of Sep 2025, the value is 0.48 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.23 Cr. (Mar 2025) to 0.48 Cr., marking an increase of 0.25 Cr..
- For Total Liabilities, as of Sep 2025, the value is 24.62 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.81 Cr. (Mar 2025) to 24.62 Cr., marking an increase of 7.81 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.19 Cr.. The value appears strong and on an upward trend. It has increased from 0.05 Cr. (Mar 2025) to 0.19 Cr., marking an increase of 0.14 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 12.92 Cr.. The value appears strong and on an upward trend. It has increased from 11.53 Cr. (Mar 2025) to 12.92 Cr., marking an increase of 1.39 Cr..
- For Other Assets, as of Sep 2025, the value is 11.51 Cr.. The value appears strong and on an upward trend. It has increased from 5.23 Cr. (Mar 2025) to 11.51 Cr., marking an increase of 6.28 Cr..
- For Total Assets, as of Sep 2025, the value is 24.62 Cr.. The value appears strong and on an upward trend. It has increased from 16.81 Cr. (Mar 2025) to 24.62 Cr., marking an increase of 7.81 Cr..
Notably, the Reserves (14.42 Cr.) exceed the Borrowings (3.80 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -1.03 | -0.30 | -2.25 | -0.58 | -0.36 | -0.04 | 0.05 | 0.04 | -0.06 | -0.01 | 0.60 | 0.57 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 36.39 | 30.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 63.97 | 79.06 | ||
| Inventory Days | 65.51 | 11.36 | ||||||||||
| Days Payable | 10.92 | 0.00 | ||||||||||
| Cash Conversion Cycle | 90.98 | 41.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 63.97 | 79.06 | ||
| Working Capital Days | 185.34 | 121.33 | -21.47 | 160.60 | 26.07 | 2,843.96 | 97.33 | 49.77 | 989.64 | 518.06 | ||
| ROCE % | -13.70% | -14.81% | -2.01% | 1.70% | 0.67% | -0.17% | 1.04% | 0.99% | -0.16% | -1.42% | 6.09% | 3.76% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 |
|---|---|
| FaceValue | 10.00 |
| Basic EPS (Rs.) | 5.17 |
| Diluted EPS (Rs.) | 4.50 |
| Cash EPS (Rs.) | 5.22 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 40.98 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 40.98 |
| Revenue From Operations / Share (Rs.) | 64.60 |
| PBDIT / Share (Rs.) | 5.79 |
| PBIT / Share (Rs.) | 5.75 |
| PBT / Share (Rs.) | 5.51 |
| Net Profit / Share (Rs.) | 5.17 |
| NP After MI And SOA / Share (Rs.) | 5.17 |
| PBDIT Margin (%) | 8.97 |
| PBIT Margin (%) | 8.89 |
| PBT Margin (%) | 8.53 |
| Net Profit Margin (%) | 8.00 |
| NP After MI And SOA Margin (%) | 8.00 |
| Return on Networth / Equity (%) | 12.62 |
| Return on Capital Employeed (%) | 11.64 |
| Return On Assets (%) | 4.88 |
| Total Debt / Equity (X) | 0.35 |
| Current Ratio (X) | 1.33 |
| Quick Ratio (X) | 1.33 |
| Interest Coverage Ratio (X) | 24.75 |
| Interest Coverage Ratio (Post Tax) (X) | 23.08 |
| Enterprise Value (Cr.) | 84.79 |
| EV / Net Operating Revenue (X) | 2.55 |
| EV / EBITDA (X) | 28.39 |
| MarketCap / Net Operating Revenue (X) | 2.27 |
| Price / BV (X) | 3.58 |
| Price / Net Operating Revenue (X) | 2.27 |
| EarningsYield | 0.03 |
After reviewing the key financial ratios for Fundviser Capital (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.17. This value is within the healthy range. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.50. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 25, the value is 5.22. This value is within the healthy range. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 40.98. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 40.98. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 64.60. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.79. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.75. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.51. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.17. This value is within the healthy range. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 5.17. This value is within the healthy range. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 25, the value is 8.97. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 25, the value is 8.89. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 25, the value is 8.53. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 25, the value is 8.00. This value is within the healthy range. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.00. This value is within the healthy range. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 25, the value is 12.62. This value is below the healthy minimum of 15. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.64. This value is within the healthy range. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 25, the value is 4.88. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.35. This value is within the healthy range. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 25, the value is 1.33. This value is below the healthy minimum of 1.5. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 25, the value is 1.33. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 24.75. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 23.08. This value is within the healthy range. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 25, the value is 84.79. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.55. This value is within the healthy range. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 25, the value is 28.39. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.27. This value is within the healthy range. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 25, the value is 3.58. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.27. This value is within the healthy range. No previous period data is available for comparison.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fundviser Capital (India) Ltd:
- Net Profit Margin: 8%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.64% (Industry Average ROCE: 21.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.62% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 23.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 156 (Industry average Stock P/E: 66.6)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.35
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | 22, 7th Floor, Manek Mahal, Next to Ambassador Hotel, Mumbai Maharashtra 400020 | info@fundvisercapital.in http://www.fundvisercapital.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Prem Krishan Jain | Chairman & Managing Director |
| Mrs. Kriti Jain | Whole Time Director |
| Mr. Triloki Nath Bansal | Independent Director |
| Mr. Vinodkumar Singh | Independent Director |
| Mr. Suresh Kumar Jain | Independent Director |
FAQ
What is the intrinsic value of Fundviser Capital (India) Ltd?
Fundviser Capital (India) Ltd's intrinsic value (as of 20 January 2026) is ₹154.61 which is 36.11% lower the current market price of ₹242.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹143 Cr. market cap, FY2025-2026 high/low of ₹281/112, reserves of ₹14.42 Cr, and liabilities of ₹24.62 Cr.
What is the Market Cap of Fundviser Capital (India) Ltd?
The Market Cap of Fundviser Capital (India) Ltd is 143 Cr..
What is the current Stock Price of Fundviser Capital (India) Ltd as on 20 January 2026?
The current stock price of Fundviser Capital (India) Ltd as on 20 January 2026 is ₹242.
What is the High / Low of Fundviser Capital (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Fundviser Capital (India) Ltd stocks is ₹281/112.
What is the Stock P/E of Fundviser Capital (India) Ltd?
The Stock P/E of Fundviser Capital (India) Ltd is 156.
What is the Book Value of Fundviser Capital (India) Ltd?
The Book Value of Fundviser Capital (India) Ltd is 34.4.
What is the Dividend Yield of Fundviser Capital (India) Ltd?
The Dividend Yield of Fundviser Capital (India) Ltd is 0.00 %.
What is the ROCE of Fundviser Capital (India) Ltd?
The ROCE of Fundviser Capital (India) Ltd is 3.76 %.
What is the ROE of Fundviser Capital (India) Ltd?
The ROE of Fundviser Capital (India) Ltd is 2.88 %.
What is the Face Value of Fundviser Capital (India) Ltd?
The Face Value of Fundviser Capital (India) Ltd is 10.0.